T1	Participants 810 921	patients with prostate cancer and treated with total androgen ablation either for three or six months before RP
T2	Participants 963 1154	259 men with prostate cancer underwent radical retropubic prostatectomy and bilateral pelvic node dissection in the 26 centres participating in the Italian randomised prospective PROSIT study
